Skip to content

CDI System 100 Monitoring System

by 3M Health Care, Ltd.

510(k) K902654

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

5 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK902654 Date5 Nov 1990ClearedStatusActive

Recalls

5 recalls · FDA

    • Terminated Z-2610-2011 FDA Unclassified (pre-2012) initiated 28 Apr 2011 on shared 510(k) K902654

    Terumo discovered through its own testing that the presence of electromagnetic interference (EMI) in the operating room may affect the accuracy of the values displayed by the CDI"101 Hematocrit/Oxygen Saturation Monitoring System: hematocrit (HCT), hemoglobin (Hgb) and Oxygen Saturation.

  • 2 recalls, same reason

    • Terminated Z-2683-2011 FDA Unclassified (pre-2012) initiated 21 Apr 2011 on shared 510(k) K902654
    • Terminated Z-2684-2011 FDA Unclassified (pre-2012) initiated 21 Apr 2011 on shared 510(k) K902654

    Inaccurate readings may result after Methylene Blue, an intravascular dye, is administered to the patient. The presence of Methylene Blue may interfere with the readings from the shunt sensor for the CDI 500 system in a way that would cause inaccurate pH values. Because the pH value is used to calculate other values, these parameters could also be affected by the presence of Methylene Blue: K

  • 2 recalls, same reason

    • Terminated Z-1943-2011 FDA Unclassified (pre-2012) initiated 1 Nov 2010
    • Terminated Z-1944-2011 FDA Unclassified (pre-2012) initiated 1 Nov 2010

    Inaccurate result. Possibility for displayed values for potassium, CO2, hematocrit, O2 saturation, pH, hemoglobin and other measured blood parameters to be inaccurate.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Cdi (Tm) System 100 Monitoring System
510(k) Number
FDA Product Code
DTY
Device Class
Class II
Regulation
21 CFR Part 870.4410
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The CDI System 100 Monitoring System is an in-line blood-gas sensor designed for use during cardiopulmonary bypass procedures. It functions as a cardiovascular monitoring device to provide real-time data on blood-gas parameters.

This device is classified as a Class 2 medical device under regulation number 870.4410. It received FDA 510(k) clearance on November 5, 1990, under the traditional clearance pathway.

Other devices from 3M Health Care, Ltd.

See all devices from 3M Health Care, Ltd. →

Questions

AI-generated answers, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical application of the CDI System 100 Monitoring System?

    The CDI System 100 is an in-line blood-gas sensor specifically designed to provide real-time monitoring of blood-gas parameters during cardiopulmonary bypass procedures.

  • What is the regulatory status of the CDI System 100?

    The device is classified as a Class 2 medical device under regulation number 870.4410 and received FDA 510(k) clearance on November 5, 1990, through the traditional pathway.

  • Who is the manufacturer of the CDI System 100 Monitoring System?

    The system is manufactured by 3M Health Care, Ltd., based in Irvine, California, and is categorized under the cardiovascular medical specialty.